DEPDC5 and epilepsy: In conclusion, our finding that postnatal focal loss of DEPDC5 is sufficient to cause seizures and neuropathological phenotypes associated with DEPDC5-related epilepsy demonstrates feasibility of gene-based therapy approaches to rescue DEPDC5 function in patients, and also provides an experimental platform for a range of future preclinical investigations.